Literature DB >> 33543132

Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer's disease neurons.

Daniel R Whiten1, Philip W Brownjohn2, Steven Moore2, Suman De1, Alessio Strano2, Yukun Zuo1, Moritz Haneklaus2, David Klenerman1,3, Frederick J Livesey2.   

Abstract

In addition to increased aberrant protein aggregation, inflammation has been proposed as a key element in the pathogenesis and progression of Alzheimer's disease. How inflammation interacts with other disease pathways and how protein aggregation increases during disease are not clear. We used single-molecule imaging approaches and membrane permeabilization assays to determine the effect of chronic exposure to tumour necrosis factor, a master proinflammatory cytokine, on protein aggregation in human-induced pluripotent stem cell-derived neurons harbouring monogenic Alzheimer's disease mutations. We report that exposure of Alzheimer's disease neurons, but not control neurons, to tumour necrosis factor induces substantial production of extracellular protein aggregates. Aggregates from Alzheimer's disease neurons are composed of amyloid-β and α-synuclein and induce significant permeabilization of lipid membranes in an assay of pathogenicity. These findings provide support for a causal relationship between two crucial processes in Alzheimer's disease pathogenesis and suggest that targeting inflammation, particularly tumour necrosis factor, may have beneficial downstream effects on ameliorating aberrant protein aggregation and accumulation.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  induced pluripotent stem cells; inflammation; presenilin-1; protein aggregation; tumour necrosis factor

Year:  2020        PMID: 33543132      PMCID: PMC7850285          DOI: 10.1093/braincomms/fcaa146

Source DB:  PubMed          Journal:  Brain Commun        ISSN: 2632-1297


  60 in total

1.  Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

Authors:  Masaru Yamamoto; Tomomi Kiyota; Masahide Horiba; James L Buescher; Shannon M Walsh; Howard E Gendelman; Tsuneya Ikezu
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 3.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2017-05-12       Impact factor: 23.643

4.  beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Authors:  E Masliah; E Rockenstein; I Veinbergs; Y Sagara; M Mallory; M Hashimoto; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity.

Authors:  Ralf P Friedrich; Katharina Tepper; Raik Rönicke; Malle Soom; Martin Westermann; Klaus Reymann; Christoph Kaether; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

6.  Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.

Authors:  Yung-Feng Liao; Bo-Jeng Wang; Hui-Ting Cheng; Lan-Hsin Kuo; Michael S Wolfe
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

7.  Systemic inflammation and disease progression in Alzheimer disease.

Authors:  C Holmes; C Cunningham; E Zotova; J Woolford; C Dean; S Kerr; D Culliford; V H Perry
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

8.  Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.

Authors:  Pravat K Mandal; Jay W Pettegrew; Eliezer Masliah; Ronald L Hamilton; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-09-01       Impact factor: 4.414

9.  Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways.

Authors:  Lewis D Evans; Thomas Wassmer; Graham Fraser; James Smith; Michael Perkinton; Andrew Billinton; Frederick J Livesey
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

10.  Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.

Authors:  Neng-Wei Hu; Grant T Corbett; Steven Moore; Igor Klyubin; Tiernan T O'Malley; Dominic M Walsh; Frederick J Livesey; Michael J Rowan
Journal:  Cell Rep       Date:  2018-05-15       Impact factor: 9.423

View more
  4 in total

1.  Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology.

Authors:  Yunseon Yang; Min-Jong Seok; Ye Eun Kim; Yunjung Choi; Jae-Jin Song; Yanuar Alan Sulistio; Seong-Hoon Kim; Mi-Yoon Chang; Soo-Jin Oh; Min-Ho Nam; Yun Kyung Kim; Tae-Gyun Kim; Heh-In Im; Seong-Ho Koh; Sang-Hun Lee
Journal:  Mol Psychiatry       Date:  2022-07-29       Impact factor: 13.437

Review 2.  Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.

Authors:  I A Clark; B Vissel
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer's disease.

Authors:  Lien Van Hoecke; Roosmarijn E Vandenbroucke; Junhua Xie; Nina Gorlé; Charysse Vandendriessche; Griet Van Imschoot; Elien Van Wonterghem; Caroline Van Cauwenberghe; Eef Parthoens; Evelien Van Hamme; Saskia Lippens
Journal:  Acta Neuropathol Commun       Date:  2021-10-07       Impact factor: 7.801

Review 4.  Neuroinflammation in Dementia-Therapeutic Directions in a COVID-19 Pandemic Setting.

Authors:  Mateusz Łuc; Marta Woźniak; Joanna Rymaszewska
Journal:  Cells       Date:  2022-09-22       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.